Risk assessment in adult acute lymphoblastic leukaemia before early haemopoietic stem cell transplantation with a geno-identical donor: an easy clinical prognostic score to identify patients who benefit most from allogeneic haemopoietic stem cell transplantation
Open Access
- 29 July 2003
- journal article
- research article
- Published by Springer Nature in Leukemia
- Vol. 17 (8), 1596-1599
- https://doi.org/10.1038/sj.leu.2403030
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- The role of posttransplantation maintenance chemotherapy in improving the outcome of autotransplantation in adult acute lymphoblastic leukemiaBlood, 2002
- Autologous Stem Cell Transplantation in Acute Lymphocytic LeukemiaThe International Journal of Cell Cloning, 2002
- Identification of novel markers for monitoring minimal residual disease in acute lymphoblastic leukemiaBlood, 2001
- Allogeneic Stem Cell Transplantation for Acute Lymphocytic Leukemia in AdultsHematology/Oncology Clinics of North America, 2001
- Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemiaBlood, 2000
- Importance of marrow dose on posttransplant outcome in acute leukemia: Models derived from patients autografted with mafosfamide-purged marrow at a single institutionExperimental Hematology, 1999
- PATHOPHYSIOLOGY AND TREATMENT OF GRAFT-VERSUS-HOST DISEASEHematology/Oncology Clinics of North America, 1999
- Detection of minimal residual disease in acute leukemia by flow cytometryCytometry, 1999
- Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantationThe Lancet, 1998
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958